Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4325064 | 0.86 | MMP3 (0.46) | MMP3KIF11HDAC8CYP2A6ENPP2 | |
| Bromide SCHEMBL10597082 | 0.84 | MMP3 (0.45) | MMP3KIF11HDAC8CYP2A6ENPP2 | |
| Hydrochloric Acid SCHEMBL2463206 | 0.84 | MMP3 (0.45) | MMP3KIF11HDAC8CYP2A6ENPP2 | |
| SCHEMBL13019484 | 0.82 | MMP3 (0.52) | MMP3KIF11CYP2A6ENPP2CA12 | |
| SCHEMBL8974055 | 0.82 | MMP3 (0.52) | MMP3KIF11CYP2A6ENPP2CA12 | |
| SCHEMBL8773276 | 0.82 | MMP3 (0.52) | MMP3KIF11CYP2A6ENPP2CA12 | |
| SCHEMBL324969 | 0.80 | CA2 (0.46) | MMP3KIF11HDAC8CYP2A6ENPP2 | |
| SCHEMBL6660002 | 0.79 | KIF11 (0.41) | MMP3KIF11HDAC8CYP2A6ENPP2 | |
| SCHEMBL19689478 | 0.77 | HDAC8 (0.61) | MMP3KIF11HDAC8CYP2A6ENPP2 | |
| SCHEMBL6660004 | 0.77 | KIF11 (0.40) | MMP3KIF11HDAC8CYP2A6ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9785030-B2 | Electrochromic composition | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-10-10 | — | — | US | disclosed |
| US-20160282694-A1 | ELECTROCHROMIC COMPOSITION | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-09-29 | — | — | US | disclosed |
| US-20160231636-A1 | ELECTROCHROMIC COMPOSITION | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-08-11 | — | — | US | disclosed |
| US-8437067-B2 | Electrochemical display element | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-05-07 | — | — | US | disclosed |
| US-8294974-B2 | Electrochromic material and electrochromic device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-10-23 | — | — | US | disclosed |
| US-20110235150-A1 | ELECTROCHROMIC MATERIAL AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-09-29 | — | — | US | disclosed |
| US-20110019265-A1 | DISPLAY ELEMENT AND METHOD OF FORMING POROUS LAYER IN DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-27 | — | — | US | disclosed |
| US-20110013261-A1 | ELECTROCHEMICAL DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110235150-A1 | ELECTROCHROMIC MATERIAL AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | EPN1, RPS3A, RPS10 | MMP3 3635/4885KIF11 700/4885HDAC8 4303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.